Journal Publications

Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.

Article Title Journal
Immune Checkpoint Inhibition in Marjolin Ulcer: A Case Series Journal of Immunotherapy
The Use of External Control Data for Predictions and Futility Interim Analyses in Clinical Trials Neuro-Oncology
Machine Learning Predicts Outcomes of Phase III Clinical Trials for Prostate Cancer Algorithms
Proton Pump Inhibitors and Survival in Patients With Colorectal Cancer Receiving Fluoropyrimidine-Based Chemotherapy Journal of the National Comprehensive Cancer Network
Evaluating predictors of renal injury with sorafenib in hepatocellular carcinoma: A multi-ethnic cohort study Journal of Onco-Nephrology
Assessment of systematic inflammatory and nutritional indexes in extensive-stage small-cell lung cancer treated with first-line chemotherapy and atezolizumab Cancer Immunology, Immunotherapy
Efficacy and adverse events of docetaxel for metastatic, hormone-sensitive prostate cancer among elderly men: post-hoc analysis of CHAARTED trial Clinical Genitourinary Cancer
Can synthetic data be a proxy for real clinical trial data? A validation study BMJ Open
Matrix decomposition in meta‐analysis for extraction of adverse event pattern and patient‐level safety profile Pharmaceutical Statistics
Assessment of a Clinical Trial–Derived Survival Model in Patients With Metastatic Castration-Resistant Prostate Cancer JAMA Network Open
Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2-) breast cancer prior to chemo-endocrine therapy Annals of Oncology
Spatiotemporal Heterogeneity Across Metastases and Organ-Specific Response Informs Drug Efficacy and Patient Survival in Colorectal Cancer Cancer Research
Predicting toxicity-related docetaxel discontinuation and overall survival in metastatic castration-resistant prostate cancer: a pooled analysis of open phase 3 clinical trial data Prostate Cancer and Prostatic Diseases
Real-world assessment of response to anti-PD-1 therapy in advanced cutaneous squamous cell carcinoma Journal of the American Academy of Dermatology

Pages